{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:06Z","timestamp":1790912466539,"version":"4.1.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,26]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Red blood cell (RBC) transfusion is a major therapy for sickle cell disease (SCD). Patients are at risk of forming antibodies to RBC antigens, which can result in the impossibility to find compatible units and can cause hemolytic transfusion reactions. This retrospective study investigates the evolution of RBC consumption and the frequencies, specificities, and chronology of the appearance of antibodies in a population of patients consistently receiving RH (C, D, E, c, e) and K\u2013matched RBC units (RBCus) from a predominantly European donor population. Over the 11-year period in the Paris area, 6496 patients received transfusion at least once for a total of 239\u2009944 units. Antibodies were made by 1742 patients. The first antibodies of a patient were predictive of subsequent immunization. By the 17th RBCu transfused (by the 20th, excluding warm autoantibodies), 75% of the patients who would make antibodies had made their first. By the 16th, 90% who would make antibodies to a high frequency antigen had made their first antibody to these antigens. Females made their first antibodies slightly earlier than males. Patients who received multiple transfusions (&amp;gt;50 units) had a higher immunization prevalence than those who rarely received transfusion (&amp;lt;12 units) but fewer clinically significant antibodies. Patients with SCD and prophylactic RH-K matching not immunized by the 20th RBCu are likely to have a low alloimmunization risk (to antigens other than RH-K), that is, be low responders, especially relative to the most clinically significant antibodies. This number of 20 units is a point before which close monitoring of patients is most important but remains open to future adjustment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2022009328","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T17:14:26Z","timestamp":1694538866000},"page":"7608-7620","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-4566","authenticated-orcid":false,"given":"Aline","family":"Floch","sequence":"first","affiliation":[{"name":"1Etablissement Fran\u00e7ais du Sang Ile-de-France, Cr\u00e9teil, France"},{"name":"2INSERM U955, Equipe Transfusion et Maladies du Globule Rouge, Universit\u00e9 Paris-Est Creteil, Institut Mondor de Recherche Biom\u00e9dicale, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Viret","sequence":"additional","affiliation":[{"name":"1Etablissement Fran\u00e7ais du Sang Ile-de-France, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Malard","sequence":"additional","affiliation":[{"name":"3Etablissement Fran\u00e7ais du Sang, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Pakdaman","sequence":"additional","affiliation":[{"name":"1Etablissement Fran\u00e7ais du Sang Ile-de-France, Cr\u00e9teil, France"},{"name":"2INSERM U955, Equipe Transfusion et Maladies du Globule Rouge, Universit\u00e9 Paris-Est Creteil, Institut Mondor de Recherche Biom\u00e9dicale, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Jouard","sequence":"additional","affiliation":[{"name":"1Etablissement Fran\u00e7ais du Sang Ile-de-France, Cr\u00e9teil, France"},{"name":"2INSERM U955, Equipe Transfusion et Maladies du Globule Rouge, Universit\u00e9 Paris-Est Creteil, Institut Mondor de Recherche Biom\u00e9dicale, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-7367","authenticated-orcid":false,"given":"Anoosha","family":"Habibi","sequence":"additional","affiliation":[{"name":"4Referral Center for Sickle Cell Disease, Henri Mondor Hospital, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Galacteros","sequence":"additional","affiliation":[{"name":"4Referral Center for Sickle Cell Disease, Henri Mondor Hospital, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"3Etablissement Fran\u00e7ais du Sang, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-3994","authenticated-orcid":false,"given":"France","family":"Pirenne","sequence":"additional","affiliation":[{"name":"1Etablissement Fran\u00e7ais du Sang Ile-de-France, Cr\u00e9teil, France"},{"name":"2INSERM U955, Equipe Transfusion et Maladies du Globule Rouge, Universit\u00e9 Paris-Est Creteil, Institut Mondor de Recherche Biom\u00e9dicale, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"issue":"7","key":"2024012314213573700_bib1","doi-asserted-by":"crossref","first-page":"e0253986","DOI":"10.1371\/journal.pone.0253986","article-title":"Epidemiology and disease burden of sickle cell disease in France: a descriptive study based on a French nationwide claim database","volume":"16","author":"Leleu","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"2024012314213573700_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"issue":"23","key":"2024012314213573700_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024012314213573700_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1423-0410.2009.01241.x","article-title":"Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases","volume":"98","author":"Natukunda","year":"2010","journal-title":"Vox Sang"},{"issue":"1","key":"2024012314213573700_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/hematology.2021000306","article-title":"How to avoid the problem of erythrocyte alloimmunization in sickle cell disease","volume":"2021","author":"Pirenne","year":"2021","journal-title":"Hematology"},{"issue":"3","key":"2024012314213573700_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.crvi.2012.09.011","article-title":"Relevance of blood groups in transfusion of sickle cell disease patients","volume":"336","author":"Noizat-Pirenne","year":"2013","journal-title":"C\u00a0R Biol"},{"issue":"6","key":"2024012314213573700_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2024012314213573700_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tmrv.2019.06.003","article-title":"Red blood cell alloimmunization in transfused patients with sickle cell disease in Sub-Saharan Africa; a systematic review and meta-analysis","volume":"33","author":"Boateng","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"1","key":"2024012314213573700_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1537-2995.2009.02382.x","article-title":"Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization","volume":"50","author":"Tournamille","year":"2010","journal-title":"Transfusion"},{"issue":"7","key":"2024012314213573700_bib10","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3324\/haematol.2014.104703","article-title":"Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype","volume":"99","author":"Silvy","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"2024012314213573700_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000490858","article-title":"Genotyping in sickle cell disease patients: the French strategy","volume":"45","author":"Floch","year":"2018","journal-title":"Transfus Med Hemother"},{"issue":"8","key":"2024012314213573700_bib12","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3324\/haematol.2021.278451","article-title":"One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel","volume":"106","author":"Boateng","year":"2021","journal-title":"Haematologica"},{"issue":"6","key":"2024012314213573700_bib13","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/trf.14633","article-title":"High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients","volume":"58","author":"Floch","year":"2018","journal-title":"Transfusion"},{"issue":"2","key":"2024012314213573700_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"2024012314213573700_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1537-2995.2006.00764.x","article-title":"Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"issue":"3","key":"2024012314213573700_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3324\/haematol.2019.224709","article-title":"Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal","volume":"105","author":"Thein","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"2024012314213573700_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"2024012314213573700_bib18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"2024012314213573700_bib19","volume-title":"Prise en charge de la dr\u00e9panocytose chez l\u2019enfant et l\u2019adolescent","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2006"},{"key":"2024012314213573700_bib20","volume-title":"Transfusions de globules rouges homologues\u202f: produits, indications, alternatives","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2014"},{"issue":"5","key":"2024012314213573700_bib21","doi-asserted-by":"crossref","first-page":"5S3","DOI":"10.1016\/S0248-8663(15)60002-9","article-title":"French guidelines for the management of adult sickle cell disease: 2015 update","volume":"36","author":"Habibi","year":"2015","journal-title":"Rev Med Interne"},{"key":"2024012314213573700_bib22","volume-title":"Applied Blood Group Serology. 1998. Reprinting","author":"Issitt","year":"2019"},{"issue":"4","key":"2024012314213573700_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"8","key":"2024012314213573700_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"key":"2024012314213573700_bib25","author":"Reid","year":"2012"},{"issue":"7","key":"2024012314213573700_bib26","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/trf.15328","article-title":"Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions","volume":"59","author":"Coleman","year":"2019","journal-title":"Transfusion"},{"issue":"1","key":"2024012314213573700_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2009.02435.x","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Uganda","volume":"50","author":"Natukunda","year":"2010","journal-title":"Transfusion"},{"issue":"4","key":"2024012314213573700_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjh.14609","article-title":"Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre","volume":"177","author":"Allali","year":"2017","journal-title":"Br J Haematol"},{"issue":"7","key":"2024012314213573700_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"2024012314213573700_bib30","first-page":"142","article-title":"Mortalit\u00e9 li\u00e9e \u00e0 la dr\u00e9panocytose en France : \u00e2ge de d\u00e9c\u00e8s et causes associ\u00e9es (1979-2010) [Sickle-cell related mortality in France: age and causes of death]","volume":"8","author":"Gomes","year":"2015","journal-title":"Bulletin \u00e9pid\u00e9miologique hebdomadaire"},{"issue":"3","key":"2024012314213573700_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.23625","article-title":"Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center","volume":"89","author":"Gueguen","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"2024012314213573700_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12185-021-03221-8","article-title":"Red blood cell exchange in children with sickle cell disease","volume":"115","author":"Elenga","year":"2022","journal-title":"Int J Hematol"},{"issue":"7","key":"2024012314213573700_bib33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder","year":"2021","journal-title":"Haematologica"},{"issue":"7","key":"2024012314213573700_bib34","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/trf.15863","article-title":"Red cell exchange for patients with sickle cell disease: an international survey of current practices","volume":"60","author":"Karafin","year":"2020","journal-title":"Transfusion"},{"issue":"14","key":"2024012314213573700_bib35","first-page":"3986","article-title":"Risks and benefits of prophylactic transfusion before cholecystectomy in sickle cell disease","volume":"11","author":"Rambaud","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"2024012314213573700_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.13294","article-title":"A\u00a0comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients","volume":"170","author":"Kuo","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"2024012314213573700_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1246-7820(05)80054-0","article-title":"Transfusion and alloimmunization in sickle cell anemia patients","volume":"1","author":"Norol","year":"1994","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"2024012314213573700_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/trf.15004","article-title":"Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)","volume":"59","author":"Karafin","year":"2019","journal-title":"Transfusion"},{"issue":"4","key":"2024012314213573700_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tmrv.2011.12.001","article-title":"Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review","volume":"26","author":"Verduin","year":"2012","journal-title":"Transfus Med Rev"},{"key":"2024012314213573700_bib40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","article-title":"The development and consequences of red blood cell alloimmunization","volume":"18","author":"Arthur","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"2024012314213573700_bib41","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","article-title":"Alloimmunization against red blood cells in sickle cell disease: challenges in high- and low-income countries","volume":"10","author":"Pirenne","year":"2023","journal-title":"Lancet Haematol"},{"issue":"10","key":"2024012314213573700_bib42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"2024012314213573700_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pbc.22985","article-title":"Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease","volume":"57","author":"Venkateswaran","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2024012314213573700_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1537-2995.1977.17678075647.x","article-title":"Autoantibodies mimicking alloantibodies","volume":"17","author":"Issitt","year":"1977","journal-title":"Transfusion"},{"issue":"1","key":"2024012314213573700_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bjhh.2016.11.002","article-title":"Red cell autoantibody mimicking anti-C specificity: a rare manifestation","volume":"39","author":"Subramaniyan","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"2024012314213573700_bib46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"issue":"6","key":"2024012314213573700_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tracli.2008.10.002","article-title":"Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply","volume":"15","author":"Meunier","year":"2008","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"2024012314213573700_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/bjh.14175","article-title":"Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures","volume":"175","author":"Stack","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"2024012314213573700_bib49","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2352-3026(16)30019-9","article-title":"Red-blood-cell alloimmunisation in relation to antigens\u2019 exposure and their immunogenicity: a cohort study","volume":"3","author":"Evers","year":"2016","journal-title":"Lancet Haematol"},{"issue":"2","key":"2024012314213573700_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tracli.2014.03.005","article-title":"Transfusion and sickle cell disease: axes of transfusion safety optimization","volume":"21","author":"Noizat-Pirenne","year":"2014","journal-title":"Transfus Clin Biol"},{"issue":"19","key":"2024012314213573700_bib51","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2009-06-227793","article-title":"Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies","volume":"114","author":"Tormey","year":"2009","journal-title":"Blood"},{"issue":"21","key":"2024012314213573700_bib52","first-page":"2642","article-title":"Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice","volume":"141","author":"Jajosky","year":"2023","journal-title":"Blood"},{"issue":"8","key":"2024012314213573700_bib53","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"issue":"4","key":"2024012314213573700_bib54","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"2024012314213573700_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/CMR.00109-14","article-title":"Blood groups in infection and host susceptibility","volume":"28","author":"Cooling","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2024012314213573700_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tracli.2019.02.003","article-title":"Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease","volume":"26","author":"Balbuena-Merle","year":"2019","journal-title":"Transfus Clin Biol"},{"issue":"3","key":"2024012314213573700_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2020-021","article-title":"Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems","volume":"35","author":"Thornton","year":"2019","journal-title":"Immunohematology"},{"issue":"7","key":"2024012314213573700_bib58","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/trf.13611","article-title":"Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients","volume":"56","author":"Ibanez","year":"2016","journal-title":"Transfusion"},{"issue":"25","key":"2024012314213573700_bib59","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/24\/7608\/2178469\/blooda_adv-2022-009328-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/24\/7608\/2178469\/blooda_adv-2022-009328-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T14:22:10Z","timestamp":1706019730000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/24\/7608\/497844\/Eleven-years-of-alloimmunization-in-6496-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":59,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009328","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}